NEWS FLASH

Outlook for the year 2008

Unaudited financial results for the quarter ended 30th June, 2006
 
 
Financials
UNAUDITED FINANCIAL RESULTS Of IND-SWIFT LABORATORIES LIMITED FOR THE QUARTER ENDED 30TH SEPTEMBER, 2002
(RS. IN LACS)
PARTICULARS
Quarter Ended 30.09.2002
Reviewed
Quarter Ended 30.09.2001 Unaudited
Six months Ended 30.9.2002 Reviewed
Six months Ended 30.9.2002 Unaudited
Year Ended 31.3.2002 Audited
 Net Sales/Operational Income
3459.34
2674.03
6294.03
5005.47
11280.92
 Others Income
10.90
22.03
20.76
28.54
40.08
 TOTAL EXPENDITURE :
3062.86
2326.44
5554.13
4395.43
9911.24
 (a) Increase/decrease in stock in trade
166.67
-77.17
294.56
69.32
73.77
 (b) Consumption of Raw Material
2792.39
1906.62
5048.85
3872.18
8638.82
 (c) Staff Cost
49.45
46.28
95.61
82.35
192.60
 (d) Other expenditure
387.69
296.37
704.23
510.22
1153.59
 Interest
166.06
153.70
322.07
265.79
617.69
 Depreciation
56.42
47.82
111.46
86.65
183.61
 Profit(+)/Loss(-) before tax
184.90
168.10
327.13
286.14
608.46
 Provision for taxation
7.87
17.00
17.87
17.00
42.00
 Provision for deferred tax
14.66
7.34
49.66
39.34
127.40
  Net Profit / Loss
162.37
143.76
259.60
229.80
439.06
 Paid up Equity Share Capital
-
-
- -
1095.58
 Reserves excluding revaluation reserves of previous accounting year
-
-
- -
1710.44
 EPS (Rs) : (Not Annulised)

   -Basic

   -Diluted
1.49
1.49
1.44
1.31
2.38
2.38
2.31
2.10
3.84
3.64
 EAggregate of non-promoters shareholding

   -BNumbers of Shares

   -Percentage of Shareholding

   
4710800
42.65%
4915800
48.93%
4615800
.41.78%
Notes:
a) During the quarter under review the turnover of the Company has increased by 29.37% and net profit after tax has increased by 12.95% over the corresponding figures of previous quarter.
b) The Company has received the coveted ISO 9001:2000 certifications, the latest International Standards for Quality Management and Quality assurance systems.
c) The Company is exclusively in the pharmaceutical business segment. The Capital employed as on 30th Sept., 2002 is 9128.18 lacs.
d) The previous period figures have been regrouped and rearranged wherever necessary.
e) The above results were taken on record by the company in its board meeting held on 30.10.2002.
 For Ind-Swift Laboratories Limited
   
       
   
Sd/-
Sd/-
 
Place:Chandigarh
(N.R.MUNJAL)
(V.K.MEHTA)
 
   
 
Date:30.07.2002
Managing Director
Jt.Managing Director
       

To know about our Formulation Division, please visit us at Ind-Swift Limited, our other group company.